Hypotensive action methyldopa.
作者信息
SMIRK H
出版信息
Br Med J. 1963 Jan 19;1(5324):146-51. doi: 10.1136/bmj.1.5324.146.
Abstract
摘要
相似文献
1
Hypotensive action methyldopa.甲基多巴的降压作用。
Br Med J. 1963 Jan 19;1(5324):146-51. doi: 10.1136/bmj.1.5324.146.
2
[alpha-Methyl-dopa, new drug with hypotensive action].[α-甲基多巴，一种具有降压作用的新药]
Boll Chim Farm. 1962 Sep;101:731-4.
3
[CLINICAL TRIAL OF A HYPOTENSIVE DRUG: 3,4-DIHYDROXY-D-L-PHENYLALANINE OR METHYLDOPA].[一种降压药物的临床试验：3,4-二羟基-D-L-苯丙氨酸或甲基多巴]
Presse Med (1893). 1964 Oct 17;72:2519-20.
4
[NEW HYPOTENSIVE DRUGS].
Med Clin (Barc). 1964 Mar;42:225-6.
5
[New hypotensive medications: guanethidine, alphamethyldopa, mecamylamine].[新型降压药物：胍乙啶、α-甲基多巴、美加明]
Vie Med. 1963 Mar;44:83-8.
6
Prolonged profound hypotension complicating severe methyldopa overdose.严重甲基多巴过量导致的持续性深度低血压并发症。
Int J Clin Pharmacol Ther. 2014 Jul;52(7):628-30. doi: 10.5414/CP202031.
7
[PRELIMINARY OBSERVATIONS ON A NEW HYPOTENSIVE AGENT: METHYLDOPA].[一种新型降压药：甲基多巴的初步观察]
Rev Bras Med. 1963 Jun;20:334-40.
8
Another hypotensive agent--methyldopa.另一种降压药——甲基多巴。
Br Med J. 1962 Jul 21;2(5298):156-8. doi: 10.1136/bmj.2.5298.156.
9
TREATMENT OF HYPERTENSION. AN EVALUATION OF ALPHA-METHYLDOPA.高血压的治疗。α-甲基多巴的评估。
Calif Med. 1963 Sep;99(3):176-7.
10
[SEVERE NEUROLOGICAL SIDE-EFFECTS IN HYPOTENSION THERAPY].[低血压治疗中的严重神经系统副作用]
Nord Med. 1964 Apr 23;71:523-5.
引用本文的文献
1
High-performance liquid chromatographic resolution of (R, S)-α-alkyl-α-amino acids as diastereomeric derivatives.高效液相色谱拆分（R，S）-α-烷基-α-氨基酸作为非对映异构体衍生物。
Amino Acids. 1993 Feb;4(1-2):157-67. doi: 10.1007/BF00805811.
2
Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison.苄胍、胍乙啶和甲基多巴治疗高血压：患者自身对照比较
Br Med J. 1968 Jan 20;1(5585):135-44. doi: 10.1136/bmj.1.5585.135.
3
Hyperpyrexia During Treatment with Methyldopa.甲基多巴治疗期间的高热
Br Med J. 1963 Jul 6;2(5348):35-6. doi: 10.1136/bmj.2.5348.35.
4
Methyldopa for primary hypertension.甲基多巴用于原发性高血压。
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003893. doi: 10.1002/14651858.CD003893.pub3.
5
SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA.关于α-甲基多巴药理学的一些观察
Br J Pharmacol Chemother. 1964 Feb;22(1):72-86. doi: 10.1111/j.1476-5381.1964.tb01545.x.
6
Methyldopa and depression.甲基多巴与抑郁症
Br Med J. 1963 Feb 23;1(5329):538-9. doi: 10.1136/bmj.1.5329.538-c.
7
Excretion patterns of tryptamine, indoleacetic acid, and 5-hydroxyindoleacetic acid, and their correlation with mental changes in schizophrenic patients under medication with alpha-methyldopa.
Psychopharmacologia. 1969;15(1):48-59. doi: 10.1007/BF00410800.
8
Hypertension and depression: interrelated problems in therapy.高血压与抑郁症：治疗中的相关问题
J R Coll Physicians Lond. 1971 Oct;6(1):14-24.
9
Editorial: Side effects of methyldopa.社论：甲基多巴的副作用
Br Med J. 1975 Mar 22;1(5959):646-7.
10
Comparative study of metoprolol and alpha-methyldopa in untreated essential hypertension.
Eur J Clin Pharmacol. 1976;10(6):375-9. doi: 10.1007/BF00563072.
本文引用的文献
1
[alpha-Methyl-DOPA. Therapeutic experiences in hypertension and biochemical research on its mode of action].[α-甲基多巴。高血压治疗经验及其作用机制的生化研究]
Schweiz Med Wochenschr. 1962 May 19;92:620-8.
2
Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension.
Am J Cardiol. 1962 Jun;9:863-7. doi: 10.1016/0002-9149(62)90211-4.
3
Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.α-甲基-3,4-二羟基-DL-苯丙氨酸对脱羧酶的抑制作用及降压效果
Science. 1960 Jun 24;131(3417):1890-1. doi: 10.1126/science.131.3417.1890.
4
Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.
Circulation. 1962 Feb;25:281-91. doi: 10.1161/01.cir.25.2.281.
5
Clinical pharmacology of newer anthypertensive agents, monoamine oxidase and decarboxylase inhibitors, bretvlium tosvlate, and guanethidine.新型抗高血压药物、单胺氧化酶和脱羧酶抑制剂、托西溴苄铵及胍乙啶的临床药理学。
Ann N Y Acad Sci. 1960 Oct 11;88:1011-20. doi: 10.1111/j.1749-6632.1960.tb20092.x.
6
[Inhibition of DOPA decarboxylase by alpha-methyl-DOPA in vivo].α-甲基多巴在体内对多巴脱羧酶的抑制作用
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;234(4):275-81.
7
[Inhibition of serotonin formation by alpha-methyl-DOPA].[α-甲基多巴对血清素形成的抑制作用]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;234(3):194-205.
8
[Effect of a decarboxylase inhibitor on the effects of dopa & dops on blood pressure].[脱羧酶抑制剂对多巴及二羟苯丝氨酸血压影响的作用]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1957;232(1):324-6.
9
Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine.
Arch Biochem Biophys. 1954 Aug;51(2):444-56. doi: 10.1016/0003-9861(54)90500-7.
Zotero 插件